Picture of Advanced Oncotherapy logo

AVO Advanced Oncotherapy News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

REG - AIM - AIM Notice - 01/07/2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220701:nRSA8983Qa&default-theme=true

RNS Number : 8983Q  AIM  01 July 2022

NOTICE

 

01/07/2022 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ADVANCED ONCOTHERAPY PLC
 21,540,000  ORDINARY SHARES OF 25P EACH, FULLY PAID  (BD6SX10)(GB00BD6SX109)

 

 ECO (ATLANTIC) OIL & GAS LTD
 2,702,702   COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)  (BYVQ3W7)(CA27887W1005)
 180,000     COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)  (BYVQ3W7)(CA27887W1005)
 33,406,531  COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)  (BYVQ3W7)(CA27887W1005)

 

 LORDS GROUP TRADING PLC
 3,986,499  ORDINARY SHARES OF 0.5P EACH, FULLY PAID  (BM9CLS5)(GB00BM9CLS53)

 

 RAMBLER METALS & MINING PLC
 2,102,400  ORDINARY SHARES OF 1 PENCE EACH FULLY PAID  (BLFJ161)(GB00BLFJ1613)

 

 VERDITEK PLC
 101,333,333  ORDINARY SHARES OF GBP0.0004 EACH FULLY PAID  (BF2C042)(GB00BF2C0424)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDLLXXDGDG

Recent news on Advanced Oncotherapy

See all news